Topics

New type of immunotherapy hinders the spread of ovarian cancer

20:00 EDT 25 Mar 2020 | AAAS

(Aarhus University) Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that on average only four out of six patients are still alive after five years. Researchers from Aarhus University, Denmark, are hoping to change this situation in the future together with research colleagues from France and the UK.

Original Article: New type of immunotherapy hinders the spread of ovarian cancer

NEXT ARTICLE

More From BioPortfolio on "New type of immunotherapy hinders the spread of ovarian cancer"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...